The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults
Semaglutide as an add-on treatment to insulin exerted relevant clinical beneficial effects on the glycometabolic control in patients with LADA. These effects are enhanced in those patients with preserved β-cell function.
Authors
- Moufida Ben Nasr (ORCID: https://orcid.org/0000-0002-1022-7853)
- Vincenzo Cimino (ORCID: https://orcid.org/0000-0002-7547-3377)
- Olga Disoteo (ORCID: https://orcid.org/0000-0002-9369-2629)
- Maria Elena Lunati (ORCID: https://orcid.org/0000-0003-3619-3046)
- Cesare Berra (ORCID: https://orcid.org/0000-0001-8431-8160)
- Elisa Lazzaroni
- Roberta Maria Fiorina
- Davide Paolo Bernasconi (ORCID: https://orcid.org/0000-0001-8771-5428)
- Loredana Bucciarelli (ORCID: https://orcid.org/0000-0001-9110-6529)
- Francesca D'Addio
- Camilla Tinari
- Andrea Rossi (ORCID: https://orcid.org/0000-0001-8575-700X)
- Laura Molteni (ORCID: https://orcid.org/0000-0001-6929-0243)
- Paola Silvia Morpurgo
- Fabrizio Losurdo
- Ida Pastore
- Paolo Fiorina
- Cristina Romano
- Alessandra Gandolfi
Institutions
- Boston Children's Hospital (US)
- University of Milan (IT)
- IULM University (IT)
- Ospedale di Circolo e Fondazione Macchi (IT)
- MultiMedica (IT)
- Istituto Clinico Sant'Ambrogio (IT)
- Post Graduate Medical Institute (PK)
- Ospedale Sant'Anna (IT)
- ASST Fatebenefratelli Sacco (IT)
- Istituto Nazionale Genetica Molecolare (IT)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-02-21
- DOI
- https://doi.org/10.1210/clinem/dgag072
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 30.73